Rozanolixizumab
- Biologic
- RYSTIGGO
Therapy management checklist
Screening, baseline and ongoing monitoring with the label's stated frequency, hold and discontinue criteria, and counseling points, each quoted from the FDA label.
Loading the therapy management checklist…
Storage and cold chain
Rozanolixizumab: storage and handling
- Refrigerate
- Yes, as the label states
Label statement
Store vials refrigerated at 36°F to 46°F (2°C to 8°C) in the original carton to protect from light until the time of use.
- Freezing
- Do not freeze
Label statement
Do not freeze.
- Room temperature
- up to 20 days at or below 25°C (77°F)
Label statement
If needed, vials may be stored at room temperature up to 77°F (25°C) for a single period of up to 20 days in the original carton to protect the vial from light.
- Back into the refrigerator
- Not allowed
Label statement
Once a vial has been stored at room temperature, it should not be returned to the refrigerator.
- Light
- Protect from light
Label statement
Store vials refrigerated at 36°F to 46°F (2°C to 8°C) in the original carton to protect from light until the time of use.
- Shaking
- Do not shake
Label statement
Do not shake.
All storage statements on the label (8)
- Store vials refrigerated at 36°F to 46°F (2°C to 8°C) in the original carton to protect from light until the time of use.
- Do not freeze.
- Do not shake.
- If needed, vials may be stored at room temperature up to 77°F (25°C) for a single period of up to 20 days in the original carton to protect the vial from light.
- Once a vial has been stored at room temperature, it should not be returned to the refrigerator.
- The discard date is 20 days after removal of the vial from the refrigerator.
- Write the discard date in the space provided on the carton.
- Discard the vial if not used within 20 days or if the expiration date has passed, whichever occurs first.
FDA label version 10, effective January 20, 2026. DailyMed
Dosing and titration calendar
Built only from the schedules the label states (loading, titration, day schedules, cycles and weight bands). Steps the label states in words the calendar cannot place are shown, not guessed.
Loading dosing schedules…
Medicare Part D coverage
No Part D formulary in the CMS files (2026Q3) lists this drug. It may be covered under Part B or not covered.
Patient assistance
No manufacturer program page is listed for this drug yet.
Independent foundations and the full directory (checked 2026-11-06). Eligibility and amounts are set by each program; open its page for them.
For licensed clinicians. Use with clinical judgment. Statements are quoted from the FDA label; confirm against the label for the product you are using.